In vitro transdermal iontophoretic delivery of leuprolide under constant current application
- 23 July 2004
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 98 (1) , 25-35
- https://doi.org/10.1016/j.jconrel.2004.04.008
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Parameters affecting the efficacy of a sustained release polymeric implant of leuprolideInternational Journal of Pharmaceutics, 2000
- Sublingual absorption of leuprolide: comparison between human and animal modelsInternational Journal of Pharmaceutics, 1999
- Biodegradable Microspheres in Drug DeliveryCritical Reviews in Therapeutic Drug Carrier Systems, 1995
- The Effects of Formulation Variables on Iontophoretic Transdermal Delivery of Leuprolide to HumansDrug Development and Industrial Pharmacy, 1993
- (D) Routes of delivery: Case studies: (6) Transdermal delivery of peptides and proteinsAdvanced Drug Delivery Reviews, 1992
- Bioavailability of Leuprolide Acetate Following Nasal and Inhalation Delivery to Rats and Healthy HumansPharmaceutical Research, 1992
- Direct Current Iontophoretic Transdermal Delivery of Peptide and Protein DrugsJournal of Pharmaceutical Sciences, 1989
- Transdermal Iontophoretic Drug Delivery: Mechanistic Analysis and Application to Polypeptide DeliveryJournal of Pharmaceutical Sciences, 1989
- Comparison Between the Lontophoretic and Passive Transport of Thyrotropin Releasing Hormone Across Excised Nude Mouse SkinJournal of Pharmaceutical Sciences, 1986
- Controlled Release of a Luteinizing Hormone-Releasing Hormone Analogue from Poly(d,l-lactide—co-glycolide) MicrospheresJournal of Pharmaceutical Sciences, 1984